Earnings Labs

Advanced Energy Industries, Inc. (AEIS)

Q3 2023 Earnings Call· Tue, Oct 31, 2023

$368.57

-4.44%

Key Takeaways · AI generated
AI summary not yet generated for this transcript. Generation in progress for older transcripts; check back soon, or browse the full transcript below.

Same-Day

-3.05%

1 Week

+0.32%

1 Month

+9.87%

vs S&P

+0.09%

Transcript

Operator

Operator

Greetings. Welcome to the Advanced Energy's Third Quarter 2023 Earnings Call. At this time, all participants are in listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions]. Please note, this conference is being recorded. At this time, I'll turn the conference over to Edwin Mok, Marketing and Investor Relations. Mr. Mok, you may begin.

Edwin Mok

Analyst

Thank you, operator. Good afternoon everyone. Welcome to Advanced Energy third quarter 2023 earnings conference call. With me today are Steve Kelley, our President and CEO; and Paul Oldham, our Executive Vice President and CFO. Before I begin, I’d like to mention that we will be participating in several investor conferences. If you have not seen our earnings press release and presentation, you can find them on our website at ir.advancedenergy.com. Let me remind you that today’s call contains forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially and are not guarantees of future performance. Information concerning these risks can be found in our SEC filings. All forward-looking statements are based on management’s estimates as of today, October 31st, 2023, and the company assumes no obligation to update them. Any targets beyond the current quarter presented today should not be interpreted as guidance. On today’s call, our financial results are presented on a non-GAAP financial basis, unless otherwise specified. Excludes our non-GAAP results are stock compensation, amortization, acquisition-related costs, facility expansion and related costs, restructuring charges and unrealized foreign exchange gain or losses. A reconciliation between GAAP and non-GAAP measures can be found in today’s press release. With that, let me pass the call to our President and CEO, Steve Kelley.

Steve Kelley

Analyst

Thanks Edwin and thanks for joining the call today. We delivered solid results in the third quarter with earnings at the high end of our guidance range on slightly lower revenue. We delivered record operating cash flow of $73 million, benefiting from improved operating margin, effective inventory control measures, and execution of our cost control initiatives. In a more challenging demand environment, we continue to deliver solid profitability and cash flow. Our strong financial performance through the business cycle gives us the freedom to invest in new products and technologies as well as improvements in manufacturing efficiency. We expect that these investments will drive future revenue growth and market share gains. We continue to make great progress on the new product front. Year-to-date, we have launched 19 new products across our markets. In addition, we have expanded our quick-turn customization activity, which enables us to quickly adapt our products to the particular needs of our customers. In our targeted markets, we are experiencing strong design win momentum in a variety of high-value applications. We continue to expect a record number of design wins in 2023, building a solid foundation for growth. To improve our operational efficiency, we are working to optimize our factory footprint with the goal of consolidating nearly all of our manufacturing into highly efficient large-scale factories. As part of that ongoing effort, we are closing two smaller factories in the current quarter. This is in addition to the Shenzhen factory closure we completed last December. Last month, we broke ground for our new flagship factory in Thailand. Construction will start next year and we expect the facility to ramp in 2025. This new Thailand factory, together with our large factories in the Philippines, Malaysia, and Mexico, will provide the capacity to meet our future needs. Supply chain…

Paul Oldham

Analyst

Thank you, Steve and good afternoon everyone. Q3 was a quarter of solid execution with earnings that came in at the high end of our guidance on slightly lower revenue. We saw some demand softening late in the quarter, largely due to macroeconomic factors. However, actions we took to improve our operations and control discretionary spending enabled us to deliver sequentially higher gross and operating margins. Together with higher interest income and lower taxes, earnings increased 16% sequentially on 1% lower revenue. Importantly, operating cash flow was at the highest level ever for the company. Finally, with shortened lead-times, customers are adjusting their order patterns and our backlog came down to $514 million. We continue to expect our backlog will settle to a level of $400 million to $500 million by the end of the current quarter. Overall, despite a softer demand environment, we believe the year is shaping up as we had expected. We are focused on driving new product activity and improving our cost structure, while preparing for the next upturn. Now, let's review our financial results in more detail. Total revenue was $410 million, down 1% sequentially and 21% from our peak quarter a year ago. Revenue in the semiconductor market was $185 million, up 7% quarter-over-quarter consistent with our view that Q2 was a near-term bottom. Revenue in the Industrial and Medical market was $115 million, down 10% from last quarter and 4% year-over-year. Following several quarters of record results, Industrial and Medical saw some softening in demand late in the quarter. Looking forward, we expect incremental revenues from prior design wins to largely offset the impact of a sluggish macroeconomic environment in Q4. Data Center computing revenue was up 16% sequentially to $68 million, due to the ramp of a hyperscale customer for AI applications.…

Operator

Operator

Thank you. At this time, we'll be conducting a question-and-answer session. [Operator Instructions] And our first question today comes from the line of Jim Ricchiuti with Needham & Company. Please proceed with your question.

Jim Ricchiuti

Analyst

Hi, good afternoon. I wanted to pursue the areas of the I&M business where you've seen some softness. I wonder if you could just maybe expand on that. And then conversely, just as you talk about some of the recent design win activity you've had there, where you see some pickup potentially offsetting some of this weakness?

Steve Kelley

Analyst

Yes Jim, this is Steve. We saw a little bit of weakness in I&M towards the end of the quarter. We actually had orders to fulfill our forecast, but we weren't able to get the kits together in time to ship in Q3. And so what we're at now is more of a short lead-time environment. So, we don't have a long-term backlog like we did for much of the past year. And so it's really on us to try to scramble and meet the needs of our customers in the short-term. That said, looking at Q4, it will be about the same as Q3 for Industrial and Medical. As we look forward into 2024, again, it's a short lead-time environment. So, our visibility is somewhat more limited as we look into next year. And I think one of the nice things about I&M, or Industrial and Medical is that there are many different submarkets, each with their own dynamics and some are up and others are down. What we see right now is probably the strongest verticals in I&M include the factory automation, the [indiscernible] segment, solar and thin film, and on the medical side, therapeutic and diagnostic type applications. I think the weakest areas right now are probably test and measurement because that's tied into semiconductor and probably some of the horticulture applications have slowed down as well. Maybe just a little more color on our Industrial and Medical. This is the one area where we sell a fair amount of product through distribution. So, roughly 45% of our I&M business goes through distributors. And so we track that inventory and the resale information pretty closely. And I can tell you, as we exited Q3, we had a little less than three months of inventory in the channel, and that's a very comfortable place for us. And the resales have actually increased each quarter in 2023. So, we think we're in pretty good shape in the distribution channel. The other thing I might just like to note is Industrial and Medical is a fairly new area for us, a new area to focus on, at least, and we've been doing it for the last two years. And I think it's making a difference. We're seeing some of the effort we put into it turn into wins and some of those wins have turned into revenue. And the other positive data point is on the customization side, which I mentioned during the call, we're seeing record turnover in the customization area. And so those two aspects where we put more focus on I&M and also doing more customization work to counteract any macroeconomic issues we face in the general market.

Jim Ricchiuti

Analyst

Got it. That's helpful color Steve. My follow-up question, and I realize you're not going to be able to be very specific. But with respect to the M&A pipeline, how much activity are you seeing in the I&M area of the business? And if you were to maybe be a little bit more specific as to whether you see more opportunities or would prefer one area versus the other in terms of where you'd like to focus on the resources?

Steve Kelley

Analyst

Yes. So, first, let me just start with the general approach to M&A that we have, and then I'll zero-in on Industrial and Medical. So, I think, first of all, we're fortunate that we're a consistent cash generator even in down cycles, we generate a lot of cash. So, it gives us the ability to make strategic investments and to go on the hunt for acquisitions. So, the types of targets we're looking for are going to be primarily in the Industrial and Medical space. We're looking for targets that are a good strategic fit, that are clearly accretive from a financial standpoint, and have a reasonable payback period. We look for companies with strong technology and/or a solid product portfolio, preferably with a significant percentage of revenue coming from sole-source products similar to our portfolio and we look for long life cycle products and technologies. So, within Industrial and Medical, we are looking for larger acquisitions, if possible. And we intend to integrate those acquisitions quickly, like we did last year with SL Power. I think that acquisition worked out pretty well for us, very complementary portfolios and helped us a lot in the medical area in particular. I think the biggest hurdles we're looking at now in M&A are just valuations. These valuations are influx and so it'll probably take longer than we would expect to get a deal done. But I think the important thing to realize is we're not in a rush to make a deal. So, we're going to maintain financial discipline. But we got nearly $1 billion sitting on our balance sheet. So, we have a lot of dry powder and I think we're an attractive acquirer.

Jim Ricchiuti

Analyst

Thanks very much. I'll jump back in the queue. Thank you.

Steve Kelley

Analyst

Thank you, Jim.

Operator

Operator

Our next question is from the line of Krish Sankar with TD Cowen. Please proceed with your question.

Krish Sankar

Analyst

Yes, hi. Thanks for taking my question. I have two of them. First one, maybe a two-part question on semi. Paul or Steve, you said semi revenues bounce on this level, so is it fair to assume flattish sequentially for December? And then along the same path, Steve, you mentioned that the semi revenue grew strong in ion implant, not dep and etch. And it seems like ion implant is more levered to mature technologies in silicon carbide. If that is true, can you help us understand how much of your semi revenue or even ion implant came from mature versus compound semi? And then I have a follow-up.

Steve Kelley

Analyst

Sure. I'll start and you can finish Paul. So basically, what we see in the entire year Krish is there has been weakness in the etch and dep market. The overall volume has been weak, and that's well known. We've been able to offset some of that weakness in three ways. One was with our service business, which has been very robust this year; the second is with design wins, which have been ramping; and the third is in the high-voltage area. And your specific question about high-voltage and where it's used? It is primarily ion implanters and to the best of my knowledge, the vast majority of that is going for mature technologies, silicon carbide as well as silicon technologies. It's there to meet the surge for high-voltage technologies or for EVs and other types of applications. So, that's about where we stand with high-voltage.

Paul Oldham

Analyst

Yes, I guess more broadly, what we said is that we still expected that semiconductor would be flat to up a little for the second half versus the first half. So, you can kind of take a look at the math there. But yes, I think bouncing around these levels, I think, is accurate. If you look at that math, you're probably flat or up a little bit in Q4. And look, as we've talked with our customers, I think they've generally said they expect business to be about flat as we look into 2024. But at the same time, we've worked hard to be, I'll say, financially prudent in terms of how we planned our business, but also be operationally prepared because we realize that when the semiconductor starts to turn, it can turn quickly and so we're prepared if we see the business start to rebound more quickly over the course of next year.

Krish Sankar

Analyst

Got it. Got it. That's very helpful. And then a follow-up on Data Center. Obviously, the Data Center revenues grew nicely like 15% Q-o-Q, but it's still down 22% on a year-over-year basis. I think, Steve, you mentioned as 1 hyperscaler customer is ramping for AI. So, I'm just kind of curious, was the incremental $10 million revenue largely driven by that one customer? Are you sole-sourced? Or is it still like multi-sourced? And kind of like what is your strategy on a go-forward basis? Because a year ago, if I'm correct, maybe the terminology is too exaggerated, but you kind of deemphasize hyperscalers and focus on I&M? So, is there a new renewed focus on Data Center? Thank you.

Steve Kelley

Analyst

Yes, that's a good question and let me just -- it's a multipart question, so I'll give you a multipart answer. So, first of all, yes, it's a soft environment today from a demand standpoint and data center. But we do have this sole-sourced design win, which we touched on last call as well as this call, and that's been ramping and has acted as a shock absorber basically. So, we're not seeing the degree of correction that some others may be because of this ramping design win. I think this is a cyclical market. We don't know exactly when the demand is going to snap back. But if history is any guide, could snap back as soon as first half 2024. Because the last time we went through this inventory digestion, it took us about three quarters to get through it. So, we're ready for a snapback in the Data Center market. We think the fundamentals are great. Still a lot of data being generated and transmitted and stored. So, the long-term story is very strong. We think there are a couple of accelerators next year, one is AI, of course. The second is the transition to 48 volts. So, we think there's some positives on the horizon for Data Center, but our strategy remains unchanged. We're still going after opportunities where we can get paid for the engineering value that we provide. And so again, we're trying to keep our margins going up and to the right, and we're not as concerned about revenue growth in Data Center.

Krish Sankar

Analyst

All right. Thanks a lot Steve. Appreciated.

Operator

Operator

Your next question is from the line of Steve Barger with KeyBanc Capital Markets. Please proceed with your question.

Steve Barger

Analyst

Thanks. You talked about inventory being in good shape in the channel. But can you expand on your comment about having a more aggressive go-to-market strategy and tie that into the efforts to cultivate distribution and VAR relationships? It seems like that will be an important force multiplier if end markets do get a little bit weaker going forward.

Steve Kelley

Analyst

Yes, Steve, I think we've done a lot on the go-to-market strategy. Let me just list some of the things that we're doing that are, I think, most important. The first is probably our website. We launched the new website in August and it's been a big hit with our customers and our distributors. If we take a look at some of the statistics, today, we're seeing roughly double number of hits on a daily basis on our website. And we've tripled the number of customers who are downloading and interacting with the website, typically downloading data sheets or application notes. So, we're very happy with that and then let me add the e-commerce capability next quarter. It does going to help us as a company, it's also going to help our distributors as well and so that's a big plus. The second big thing we did was on the sales side, where we basically split our sales force into two parts and one of those parts is focused exclusively on Industrial and Medical. So, those people, the apps engineers and the sales engineers only get paid on Industrial and Medical design wins and revenue. So, it's been -- its brought a tremendous amount of focus to our effort, not just through distributors, but also directly with customers. So, that's been a big plus for the company. And thirdly, I think we've raised our game in the marketing communications area and our ability to train our distributors and salesforce and how to sell our product and how they fit from a customer standpoint. So, I think we're in much better shape than were two years ago.

Paul Oldham

Analyst

I'll just add to that, Steve. I think our prepared comments were such that we think the inventory and the distribution channel is about right, but we've actually seen more sell-through. And you're right, as market forces potentially weaken, getting broader reach is one of our primary strategies and the distribution channel is certainly a key part of that. And there's even potential for us to expand further from a distribution channel perspective as we focused on that.

Steve Barger

Analyst

Got it. Thanks. And Paul, backlog is down about 50% year-over-year to $514 million, which I think is at the high end of what you consider a more normal range. Can you talk through segment exposure in backlog, timing of delivery? And maybe talk through book-to-bill for semiconductor and Industrial and Medical?

Paul Oldham

Analyst

Yes. So, you're right, the backlog is down. Frankly, the backlog we had a year ago is extremely unusual. If you go back historically before the part shortages we saw, roughly 24 to 30 months ago, we would typically carry backlog that was 60% of quarterly revenue. And that's because a lot of our products are relatively short lead-times, and we have many customers who don't technically give us orders. So, there's not really a book-to-bill because we fill revenue through jet bins or through hub pulls. And we'd expect to move back towards that situation, and that's exactly what's happening. I think by the end of this Q4, we'll be back well within that $400 million to $500 million range. About $400 million is about a quarter's worth of backlog. That's probably a quarter or quarter plus is kind of probably where things will run, probably a little more than they did historically. So, we think the contraction in backlog is pretty natural and it mainly just reflects those shorten lead-times and people returning to their normal ordering patterns. From that perspective, if you look at what's in backlog, the majority of it is relatively short orders now, I'd say, within a quarter-and-half or less. It's also still heavily weighted towards Industrial and Medical and Semiconductor. And as we look forward, again, it's hard to say a particular book-to-bill because many of our customers don't order that way.

Steve Barger

Analyst

Got it. Appreciate the detail. Thanks.

Operator

Operator

Our next question is from the line of Mehdi Hosseini with SIG. Please proceed with your question.

Mehdi Hosseini

Analyst

Yes, thanks for taking my question. Paul, I just want to go back to the backlog. When I look at commentary by some of your customers in Industrial and Semi, it seems like they don't really have a whole lot of visibility looking into calendar year 2024. And as such, could there be a scenario where your backlog would actually move towards the low end of that $400 million to $500 million band?

Paul Oldham

Analyst

Yes, I think it could. Again, our estimate there is a little bit of a -- based on market factors and where things could end up. Historically, we've run under that level and that would be normal. So, I think as customers move back to more normalized patterns, we could certainly move towards the low end of that. That wouldn't be a surprise. Again, that would still be about a quarter's worth of backlog, which should be higher than the historical norm.

Mehdi Hosseini

Analyst

Okay. And then just double-clicking on your semi business. If your customers are right now think -- elaborate or talking about 2024 as a flat in terms of the system shipment or system revenue compared to 2023, does that imply that just some inventory refresh of components would lead to some growth in Advanced Energy's Semiconductor business unit?

Steve Kelley

Analyst

Yes, I think that's a fair scenario, Mehdi. Like you said, the customer consensus seems to be that their end customer shipments will be roughly flat year-on-year. But we do see some room for growth in the jet bins and we see some room for growth in our new products as well. And that should push us into slight growth year-on-year.

Mehdi Hosseini

Analyst

Yes, got it. Thank you.

Operator

Operator

Thank you. [Operator Instructions] The next question is from the line of Mark Miller with Benchmark. Please proceed with your question.

Mark Miller

Analyst

Thank you for the question. You talked about the implant was driving your high-voltage opportunity. In the last couple of weeks, there's been concern about slowing in the EV market. EV sales in China this past quarter were down 27% sequentially. Are you seeing any slowing of quoting activity or orders as a result of this? Ford also delayed its capacity additions because of slowness.

Steve Kelley

Analyst

Yes, Mark, the short answer is no, we have not seen that. So, right now, our backlog is still very robust, very strong. And we're not getting any signals yet from our customers that they're going to bring the forecast downward.

Mark Miller

Analyst

Next question, Telecom, are any of your customers dealing with an inventory digestion situation?

Steve Kelley

Analyst

And your question was specific to Telecom?

Mark Miller

Analyst

Correct.

Steve Kelley

Analyst

Or just in general?

Mark Miller

Analyst

Just Telecom.

Steve Kelley

Analyst

Just Telecom.

Paul Oldham

Analyst

I'm not aware that they're dealing with a lot of inventory, but it's also clear if you look at the telecom manufacturers, they're in a pretty severe down cycle right now. So, I don't think there's a lot of inventory overhang there, but also, there's not a lot of orders. It's one of the reasons we talked in our prepared remarks about that we would anticipate that our Telecom and Network business is continuing to trend back towards a $30 million run rate versus where it's ran the last -- most of the last year.

Mark Miller

Analyst

Thank you.

Operator

Operator

Thank you. The next question is from the line of Pavel Molchanov with Raymond James. Please proceed with your question.

Pavel Molchanov

Analyst

Yes, thanks for taking the question. We're talking about all of the macroeconomic headwinds in a lot of the verticals. But you also said that valuation prospective M&A are too expensive. From the perspective of the sellers who are insisting on these high-deal model, what are they looking at?

Steve Kelley

Analyst

I can only comment for Advanced Energy. And I think valuations have adjusted over the past a year and a half. And I think different parties adjust the new valuation at different rates and I think that's going to -- I think the answer to your question is going to vary depending on which target we're talking about. But we think over the next six to 12 months, we'll probably be able to come to a deal with one or more of these targets. But again, it's going to depend on if it makes financial sense for Advanced Energy and strategic sense for the company.

Pavel Molchanov

Analyst

Right. You also mentioned that for M&A, you're looking for kind of chunkier deal sizes versus maybe what you would consider historically. If Artesyn was the largest M&A deal in the company's history, compared to that, are you looking to do something even larger?

Steve Kelley

Analyst

I think it's one of our goalpost, I would say, SL Power would be the smallest kind of deal we would like to do in I&M and Artesyn would be the largest type of deal. So, it's going to be somewhere in between those two goalposts.

Pavel Molchanov

Analyst

Okay, that's interesting. And lastly, within Industrial and Medical, I periodically ask this question, more and more headlines about new solar manufacturing, not just in the United States, but more broadly outside of China. Can you talk about your opportunities in that infrastructure build-out?

Steve Kelley

Analyst

Yes, I think in solar, our primary opportunity is probably in the plasma space where many of these solar cells, solar panels need extremely precise thin layers of various things deposited on flat service. And this is an ideal type of application for plasma. And so we provide basically RF solutions for Intel manufacturers, which includes solar.

Pavel Molchanov

Analyst

All right. Thanks very much.

Steve Kelley

Analyst

Thank you.

Operator

Operator

Thank you. Ladies and gentlemen, this will conclude today's -- you may disconnect your lines at this time and thank you for your participation.